single-vessel disease

single-vessel disease

Coronary heart disease in which one coronary artery has significant narrowing/stenosis. Single-vessel disease can be managed by stenting, angioplasty or coronary artery bypass.
References in periodicals archive ?
Patients were assigned according to the number of coronary arteries affected by significant stenosis as having single-vessel disease, two-vessel disease, or multi-vessel disease.
The Octopus population comprised 280 low-risk patients with preserved left ventricular function, single-vessel disease, and a mean age of 60 years.
FAME confirms the benefits of routine FFR for the multi-vessel patient just as the earlier Deferral versus Performance of PTCA in Patients Without Documented ischemia (DEFER) study demonstrated in single-vessel disease, but does so in a larger patient population and in a randomized fashion," commented Morton Kern, MD, professor of medicine and associate chief, Division of Cardiology, University of California, Irvine.
The COSTAR II trial compared the CoStar(R) stent with the Taxus Express(2) paclitaxel drug-eluting stent, and was designed to demonstrate non-inferiority at eight-month follow-up with respect to major adverse cardiac events (MACE) in patients with multi-vessel or single-vessel disease.
1% rate among 377 others with angiographically significant single-vessel disease not treated with angioplasty or bypass surgery.
Based on the above definitions, we enrolled 20 patients with single-vessel disease (SVD group), 20 patients with double-vessel disease (DVD group) and 20 patients with three-vessel disease (TVD group).
It was formerly shown that patients with three-vessel coronary artery disease and preserved systolic function have a higher mortality at 5 years follow-up as compared to those with single-vessel disease (6).
Women have higher rates of nonobstructive and single-vessel disease, which highlights the need for prevention, as well as recognition of the diagnostic challenge this poses for clinicians.
Key words: single-vessel disease, resting ECG, body surface potential mapping, ST-T isointegral maps
The study was undertaken because PTA has become the first choice of therapy for most patients with single-vessel disease, but it neither stops the underlying progressive atherosclerosis nor entirely clears the vessel of plaque.